What DEA's Special Registrations Mean for Telehealth Prescribing

Telehealth prescribing of controlled substances has been the source of intense debate and discussion for the last several years. Though much is still unknown about its future, the DEA did make good on a decades-long directive from Congress, releasing a proposal for a special registrations framework that would provide designated pathways to telehealth prescribing of controlled substances. It was met with immediate and vehement backlash from telehealth stakeholders.The American Telemedicine Association's advocacy arm, ATA Action, stated that finalizing the proposal would be a "major setback" for the industry and urged President Donald Trump to withdraw the draft. The Alliance for Connected Care noted the proposal may restrict access to telehealth, which would "lead to harsh consequences for many Americans relying on telehealth for mental health, substance use disorder, sleep disorders, terminal illness and many other medical issues."

Medigy Insights

In a proposed rule made available on the Federal Register in January, the DEA outlined three types of registrations that would allow healthcare practitioners to prescribe controlled substances via telehealth.The first, the telemedicine prescribing registration, would authorize qualified clinician practitioners to prescribe Schedule III-V controlled substances via telehealth. The second, the advanced telemedicine prescribing registration, would allow specialized clinician practitioners, such as psychiatrists and hospice care physicians, to prescribe Schedule II-V controlled substances via telehealth.

Continue reading at techtarget.com

Make faster decisions with community advice

UM Team Cracks New Approach to Glucose Monitoring with Egg White Biosensors

Current glucose monitoring methods often require invasive finger pricks or expensive continuous glucose monitors, both of which present challenges for individuals managing diabetes.This research …

Posted Mar 3, 2025